IMC Chicago’s GeneDx Holdings WGS Stock Holding History

IMC Chicago’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.26M	Sell	35,200 -39,000	-53%	-$3.56M	﹤0.01%	2453
2025 Q4	$9.65M	Buy	74,200 +9,000	+14%	+$1.24M	﹤0.01%	1248
2025 Q3	$7.02M	Sell	65,200 -49,000	-43%	-$5.34M	﹤0.01%	1349
2025 Q2	$10.5M	Buy	114,200 +89,300	+359%	+$7.01M	﹤0.01%	993
2025 Q1	$2.21M	Buy	+24,900	New	+$2.16M	﹤0.01%	1739

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

IMC Chicago's WGS Position: Q1 2026 in Review

IMC Chicago opened a new position in GeneDx Holdings (WGS) in Q1 2026: 4,643 shares worth $298K. The stake represents ﹤0.01% of the portfolio and ranks #4594 among its holdings.

240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

IMC Chicago held 4,643 shares of GeneDx Holdings worth $298K as of Q1 2026.
GeneDx Holdings was a new IMC Chicago position in Q1 2026.
GeneDx Holdings made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4594 holding.
240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.